Either the adjuvanted influenza vaccine, Fluad Quad (NIP-funded) or the high dose influenza vaccine, Fluzone High Dose Quadrivalent is recommended in preference to standard influenza vaccine for adults aged ≥65 years. See also Vaccine information.
Influenza-associated mortality rates are highest among adults aged ≥65 years.4 Vaccinating elderly people reduces hospitalisations from influenza and pneumonia, and all-cause mortality.8
The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.